Takeda Pharmaceutical Company Limited (TAK) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Takeda Pharmaceutical Company Limited (TAK) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

TAK Income Statement

Takeda Pharmaceutical Company Limited (TAK) annual income statement — 26-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21	Q2'21

Sales/Revenue	1.22T	1.11T	1.21T	1.11T	1.11T	1.05T	1.14T	1.18T	1.21T	1.05T	1.11T	1.04T	1.06T	956.16B	1.1T	1T	972.47B	873.29B	901.29B	844.82B
Revenue Growth %	10.23%	5.81%	6.04%	-5.38%	-8.39%	0.24%	2.96%	12.75%	14.11%	9.91%	1.33%	4.07%	8.86%	9.49%	21.66%	18.64%	2.41%	13.37%	7.71%	7.08%
Cost of Goods Sold	406.68B	570.84B	552.87B	380.06B	384.68B	382.1B	416.87B	394.31B	386.95B	387.33B	379.48B	343.58B	321.11B	309.77B	335.97B	305.44B	292.88B	308.38B	281.4B	275.8B
COGS % of Revenue	33.34%	51.21%	45.57%	34.15%	34.76%	36.27%	36.44%	33.53%	32.03%	36.86%	34.15%	32.94%	30.33%	32.4%	30.64%	30.47%	30.12%	35.31%	31.22%	32.65%
Gross Profit	813.22B	543.81B	660.35B	732.74B	722.01B	671.3B	727.25B	781.73B	821.04B	663.54B	731.71B	699.51B	737.5B	646.38B	760.58B	696.86B	679.58B	564.91B	619.89B	569.02B
Gross Margin %	66.66%	48.79%	54.43%	65.85%	65.24%	63.73%	63.56%	66.47%	67.97%	63.14%	65.85%	67.06%	69.67%	67.6%	69.36%	69.53%	69.88%	64.69%	68.78%	67.35%
Gross Profit Growth %	12.63%	-18.99%	-9.2%	-6.27%	-12.06%	1.17%	-0.61%	11.75%	11.33%	2.65%	-3.8%	0.38%	8.52%	14.42%	22.7%	22.47%	-4.06%	9.3%	6.22%	5.51%
Operating Expenses	611.81B	496.27B	466.28B	663.74B	537.44B	746.2B	660.31B	597.48B	654.71B	673.61B	626.79B	748.85B	568.93B	557.82B	613.59B	592.42B	529.07B	566.53B	503.4B	471.6B
OpEx % of Revenue	50.15%	44.52%	38.43%	59.65%	48.56%	70.84%	57.71%	50.8%	54.2%	64.1%	56.41%	71.79%	53.74%	58.34%	55.96%	59.11%	54.4%	64.87%	55.85%	55.82%
Selling, General & Admin	286.51B	297.36B	287.89B	253.55B	255.88B	295.9B	270.59B	268.28B	270.03B	285.23B	267.52B	252.95B	248.11B	254.8B	262.3B	248.73B	231.48B	223.43B	231.08B	212.01B
SG&A % of Revenue	23.49%	26.68%	23.73%	22.79%	23.12%	28.09%	23.65%	22.81%	22.35%	27.14%	24.08%	24.25%	23.44%	26.65%	23.92%	24.82%	23.8%	25.58%	25.64%	25.1%
Research & Development	167.4B	198.91B	178.39B	161.48B	143.89B	216B	170.19B	175.56B	168.46B	195.86B	187.38B	183.95B	162.74B	160.94B	174.63B	154.15B	143.61B	143.63B	128.38B	131.6B
R&D % of Revenue	13.72%	17.84%	14.7%	14.51%	13%	20.51%	14.88%	14.93%	13.95%	18.64%	16.86%	17.63%	15.37%	16.83%	15.93%	15.38%	14.77%	16.45%	14.24%	15.58%
Other Operating Expenses	1000K	0	0	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Operating Income	201.42B	47.54B	194.06B	69B	184.57B	-74.9B	66.94B	184.25B	166.33B	-10.07B	104.91B	-49.34B	168.57B	88.56B	146.99B	104.44B	150.51B	-1.62B	116.48B	97.43B
Operating Margin %	16.51%	4.27%	16%	6.2%	16.68%	-7.11%	5.85%	15.67%	13.77%	-0.96%	9.44%	-4.73%	15.92%	9.26%	13.4%	10.42%	15.48%	-0.19%	12.92%	11.53%
Operating Income Growth %	9.13%	163.47%	189.9%	-62.55%	10.96%	-643.87%	-36.19%	473.42%	-1.33%	-111.37%	-28.63%	-147.24%	12%	5570.17%	26.19%	7.2%	-39.44%	-101.08%	-18.62%	101.7%
EBITDA	312.35B	214.42B	388.14B	274.15B	366.2B	114.87B	253.9B	376.7B	358.55B	93.13B	291.98B	190.9B	340.07B	249.97B	323.87B	272.26B	308.8B	150.66B	263.77B	238.07B
EBITDA Margin %	25.6%	19.24%	31.99%	24.64%	33.09%	10.9%	22.19%	32.03%	29.68%	8.86%	26.28%	18.3%	32.12%	26.14%	29.54%	27.16%	31.75%	17.25%	29.27%	28.18%
EBITDA Growth %	-14.71%	86.67%	52.87%	-27.22%	2.13%	23.34%	-13.04%	97.33%	5.43%	-62.74%	-9.85%	-29.88%	10.13%	65.92%	22.79%	14.36%	-21.12%	-48.04%	-6.76%	27.14%
D&A (Non-Cash Add-back)	110.93B	166.88B	194.08B	205.16B	181.64B	189.77B	186.96B	192.45B	192.22B	103.2B	187.06B	240.24B	171.5B	161.41B	176.88B	167.83B	158.28B	152.27B	147.28B	140.65B
EBIT	226.56B	-8.99B	262.14B	111.31B	257.79B	-8.5B	6.05B	187.83B	196.29B	156.03B	69.97B	-37.96B	194.61B	38.12B	186.9B	118.35B	210.94B	-20.87B	118.9B	101.12B
Net Interest Income	-39.24B	-39.2B	-36.4B	-38.74B	-33.4B	-207.21M	-207.35M	-64.34B	-29.01B	-277.45M	-44.78B	-336.63M	-33.12B	-265.49M	-38.07B	-39.02B	5.46B	-24.26B	-42.56B	-32.81B
Interest Income	24.61B	5.25B	89.46B	44.4B	73.76B	122.99M	0	4.12B	30.68B	40.36M	21.79B	64.74M	26.45B	58.79M	41.68B	14.78B	60.92B	0	4.14B	6.86B
Interest Expense	63.84B	44.45B	125.86B	83.14B	107.16B	330.2M	207.35M	68.45B	59.69B	317.81M	66.57B	401.37M	59.58B	324.28M	79.75B	53.8B	55.47B	24.26B	46.71B	39.68B
Other Income/Expense	-38.7B	-100.98B	-57.78B	-40.82B	-33.94B	-32.4B	-40.53B	-64.88B	-29.73B	-37.45B	-43.65B	-46.64B	-33.12B	-40.65B	-39.84B	-39.02B	5.46B	-52.43B	-44.29B	-35.98B
Pretax Income	162.72B	-53.44B	136.28B	28.17B	150.63B	-107.3B	26.41B	119.37B	136.6B	-47.52B	61.26B	-95.98B	135.45B	47.91B	107.15B	65.42B	155.97B	-54.05B	72.19B	61.45B
Pretax Margin %	13.34%	-4.79%	11.23%	2.53%	13.61%	-10.19%	2.31%	10.15%	11.31%	-4.52%	5.51%	-9.2%	12.8%	5.01%	9.77%	6.53%	16.04%	-6.19%	8.01%	7.27%
Income Tax	49.46B	-28.74B	30.67B	39.9B	26.35B	-4.2B	2.57B	27.27B	41.3B	-44.53B	-44.5B	-48.01B	45.63B	16.78B	-12B	2.82B	50.45B	-42.67B	14.37B	15.45B
Effective Tax Rate %	30.4%	53.78%	22.51%	141.63%	17.49%	3.91%	9.74%	22.84%	30.24%	93.7%	-72.63%	50.02%	33.69%	35.02%	-11.2%	4.31%	32.35%	78.95%	19.91%	25.15%
Net Income	113.2B	-24.77B	105.51B	-11.8B	124.24B	-103.2B	23.79B	92.05B	95.25B	-3.02B	105.72B	-48.03B	89.39B	31.13B	119.13B	61.74B	105.01B	-11.36B	57.77B	45.96B
Net Margin %	9.28%	-2.22%	8.7%	-1.06%	11.23%	-9.8%	2.08%	7.83%	7.88%	-0.29%	9.51%	-4.6%	8.44%	3.26%	10.86%	6.16%	10.8%	-1.3%	6.41%	5.44%
Net Income Growth %	-8.89%	76%	343.52%	-112.82%	30.44%	-3319.48%	-77.5%	291.64%	6.55%	-109.69%	-11.25%	-177.79%	-14.87%	374.12%	106.21%	34.33%	-23.73%	-105.76%	-37.45%	1038.57%
Net Income (Continuing)	113.26B	-24.7B	105.61B	-11.73B	124.28B	-103.1B	23.84B	92.11B	95.3B	-2.99B	105.76B	-47.97B	89.82B	31.14B	119.15B	62.6B	105.52B	-11.38B	57.82B	45.99B
Discontinued Operations	0	0	0	0	0	0	0	1000K	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	989M	1.21B	1.15B	992M	921M	895M	917M	843M	815M	741M	673M	673M	617M	549M	520M	560M	551M	504M	493M	426M
EPS (Diluted)	35.27	-7.92	32.92	-3.74	39.12	-32.62	7.51	28.59	29.97	-0.96	33.35	-15.34	28.56	9.65	37.93	19.74	33.78	-3.60	18.34	14.54
EPS Growth %	-9.84%	75.72%	338.35%	-113.08%	30.53%	-3297.92%	-77.48%	286.38%	4.94%	-109.95%	-12.07%	-177.71%	-15.45%	368.06%	106.82%	35.76%	-23.73%	-105.76%	-37.43%	1027.13%
EPS (Basic)	35.83	-7.92	33.40	-3.74	39.70	-32.62	7.51	29.07	30.36	-0.96	33.69	-15.34	28.76	10.02	38.32	19.89	33.97	-3.65	18.45	14.62
Diluted Shares Outstanding	3.21B	3.12B	3.2B	3.15B	3.18B	3.16B	3.17B	3.22B	3.18B	3.14B	3.17B	3.13B	3.13B	3.23B	3.14B	3.13B	3.11B	3.15B	3.15B	3.16B
Basic Shares Outstanding	3.16B	3.12B	3.16B	3.15B	3.13B	3.16B	3.17B	3.17B	3.14B	3.14B	3.14B	3.13B	3.11B	3.11B	3.11B	3.1B	3.09B	3.11B	3.13B	3.14B
Dividend Payout Ratio	132.63%	-	141.25%	-	116.94%	-	611.42%	9.99%	145%	-	130.77%	-	146.26%	33.47%	108.28%	18.03%	122.72%	-	227.54%	20.76%